SBC Medical Group Holdings Inc. has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking its official entry into the American market. The partnership enables SBC, which operates 258 affiliated clinics worldwide and manages over six million patient visits annually, to leverage OrangeTwist's 24 locations across six states. The collaboration focuses on joint operations, with plans to develop branded products and sell existing offerings in each other's facilities, creating synergies in both the U.S. and Asian markets.
The medical aesthetics industry is projected to grow from $34 billion to $48 billion by 2030, driven by demand for non-surgical treatments like injectables, fillers, and laser therapies. SBC aims to address "white space" in the U.S. market—cities with high demand but few competitors—by combining resources with OrangeTwist to secure first-mover advantages. Stephen Rodgers, global head of planning and strategy at SBC Medical, emphasized the company's strategy of forming local partnerships rather than replicating its Japanese model, seeking partners that align with its mission and can scale effectively.
Beyond aesthetics, SBC is positioned to capitalize on the global longevity industry, valued at approximately $85 billion in 2025 and expected to surpass $120 billion by 2030, according to Gabelli Research. The industry's shift toward enhancing "healthspan" through personalized, tech-driven solutions aligns with SBC's infrastructure and expertise. North America accounts for about 30% of the market, while Asia shows robust growth due to beauty-conscious consumers and an aging population.
SBC's expansion strategy extends beyond the U.S., including growth in Japan and Southeast Asia. The company applies its proven business model to assist Asian clinics with management services, staff training, and equipment pricing. By standardizing non-invasive treatments, which are popular in Asian markets for their natural results and minimal recovery times, SBC ensures consistent quality and pricing across regions like Japan, Thailand, and Singapore.
The company's global approach rests on three tenets: partnering with scalable regional operators, deploying SBC's expertise to optimize performance, and securing innovation-driven advantages. This model aims to build a trusted, worldwide brand for aesthetic services, transforming SBC from a local operator into a global network. The partnership with OrangeTwist, supported by institutional shareholders like Hildred Capital and Athyrium Capital, underscores SBC's commitment to leveraging its clinical capabilities and operational systems for international growth.
